Ocugen Inc. (OCGN) Financial Statements (2024 and earlier)

Company Profile

Business Address 11 GREAT VALLEY PARKWAY
MALVERN, PA 19355
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments39,46290,93494,95824,0397,44415,542
Cash and cash equivalents39,46277,56394,95824,0397,44415,542
Short-term investments  13,371    
Prepaid expense      686
Advances on inventory purchases   4,988   
Asset, held-for-sale, not part of disposal group     7,000 
Other current assets      172
Other undisclosed current assets3,5097,5582,7001,8381,322 
Total current assets:42,97198,492102,64625,87815,76616,400
Noncurrent Assets
Property, plant and equipment17,2906,0531,164633222141
Restricted cash and investments   151151151137
Other noncurrent assets4,2864,0871,800714668750
Total noncurrent assets:21,57610,1403,1151,4991,0411,028
TOTAL ASSETS:64,547108,632105,76127,37616,80717,428
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,11417,9625,0683,3254,1662,590
Employee-related liabilities1,716   
Accounts payable3,1728,0622,3123951,8961,590
Accrued liabilities1,9429,9001,0402,9302,2701,000
Debt   234172 
Deferred rent credit      45
Other liabilities    10206 
Deferred lease income  238
Other undisclosed current liabilities11,9754981,93244  
Total current liabilities:17,08918,4607,0003,6144,5442,873
Noncurrent Liabilities
Long-term debt and lease obligation2,8002,2892,9432,2121,235 
Long-term debt, excluding current maturities2,8002,2891,7121,8231,072 
Liabilities, other than long-term debt4,0943,831  1013,988
Accounts payable and accrued liabilities      2,512
Contract with customer, liability10,000
Deferred rent credit      351
Due to related parties    1,125
Other liabilities527244  10 
Operating lease, liability3,5673,5871,231389163
Other undisclosed noncurrent liabilities   (1,231)(389) 1,025
Total noncurrent liabilities:6,8946,1202,9432,2121,24515,013
Total liabilities:23,98324,5809,9435,8265,78917,886
Equity
Equity, attributable to parent, including:40,56484,05295,81821,55011,018(458)
Common stock2,5672,2171,9951,841527513
Treasury stock, value(48)(48)(48)(48)(48) 
Additional paid in capital324,191294,874225,53793,05962,019215,859
Accumulated other comprehensive income2026    
Retained earnings (accumulated deficit)(286,167)(213,018)(131,667)(73,302)51,480(216,830)
Other undisclosed equity, attributable to parent111 (102,960) 
Total equity:40,56484,05295,81821,55011,018(458)
TOTAL LIABILITIES AND EQUITY:64,547108,632105,76127,37616,80717,428

Income Statement (P&L) ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues6,036  43  
Cost of revenue
(Provision for Loan, Lease, and Other Losses)
   (761)   
Gross profit:6,036 (761)43  
Operating expenses(71,567)(84,868)(58,028)(21,327)(14,163)(30,108)
Other undisclosed operating income  761   
Operating loss:(65,531)(84,868)(58,028)(21,285)(14,163)(30,108)
Nonoperating income (expense)2,4533,517(389)(537)(6,080)21,465
Other nonoperating income (expense)   (310)183(785)(106)
Interest and debt expense   426(721)(1,768)1,540
Other undisclosed loss from continuing operations before equity method investments, income taxes      (1,540)
Loss from continuing operations before equity method investments, income taxes:(63,078)(81,351)(57,991)(22,543)(22,010)(8,643)
Other undisclosed loss from continuing operations before income taxes   (426)   
Loss from continuing operations before income taxes:(63,078)(81,351)(58,417)(22,543)(22,010)(8,643)
Income tax benefit   52   
Loss from continuing operations:(63,078)(81,351)(58,365)(22,543)(22,010)(8,643)
Loss before gain (loss) on sale of properties:(58,365)(22,543)(22,010)(8,643)
Other undisclosed net income    7211,768 
Net loss attributable to parent:(63,078)(81,351)(58,365)(21,822)(20,243)(8,643)
Preferred stock dividends and other adjustments    (12,546)  
Other undisclosed net income available to common stockholders, basic      121
Net loss available to common stockholders, basic:(63,078)(81,351)(58,365)(34,368)(20,243)(8,522)
Dilutive securities, effect on basic earnings per share      (20,601)
Net loss available to common stockholders, diluted:(63,078)(81,351)(58,365)(34,368)(20,243)(29,123)

Comprehensive Income ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(63,078)(81,351)(58,365)(21,822)(20,243)(8,643)
Other comprehensive income (loss)(6)26    
Other undisclosed comprehensive loss      
Comprehensive loss:(63,084)(81,325)(58,365)(21,822)(20,243)(8,643)
Other undisclosed comprehensive loss, net of tax, attributable to parent    (0) 
Comprehensive loss, net of tax, attributable to parent:(63,084)(81,325)(58,365)(21,822)(20,243)(8,643)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: